Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)

Table 3 AHCL system characteristics during the study

	First two weeks in AHCL	Third Month in AHCLS	P
Sensor wear, %	92.7 ± 10.1	95.8 ± 5.3	0.118
AHCL usage, %	88.4 ± 5.7	91.8 ± 3.2	0.003
SMBG, n per day	5.5 ± 1.2	3.4 ± 0.9	0.001
Set change, n of days	2.5 ± 0.5	2.5 ± 0.7	1.000
Res change, n of days	2.8 ± 0.6	2.7 ± 0.6	0.494
Meals, n per day	4.4 ± 1.2	5.2 ± 1.9	0.042
Carbs, gr per day	209 ± 78	213 ± 79	0.834
ICR, gr	11.3 ± 6.9	8.5 ± 3.8	0.042
AIT, h	2.6 ± 0.7	2.5 ± 0.6	0.523
Exit from AHCL per patient per week	0.7 ± 0.8	0.5 ± 0.7	0.221

Values are shown as mean ± SD. *Values shown as mean and SD
n Number, AIT Active Insulin Time, Res Reservoir, Carbs Carbohydrates, ICR Insulin to carb ratio, SG Sensor glucose, Max maximum, AHCL Advanced Hybrid Closed Loop System

ISSN: 1472-6823